Cure My Disease

Don't miss your cure!

 Log in / Sign up

Grape juice could replace nasty sugar drink in pregnancy test

NCT ID NCT07323901

Diagnosis Sponsor: Bnai Zion Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores whether a glass of grape juice can replace the standard sugary drink used to screen for gestational diabetes. Pregnant individuals at 24-28 weeks will take both tests and compare blood sugar levels and satisfaction. The goal is to find a more pleasant option that still accurately detects diabetes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
grape juice
What this could lead to
If successful, this could offer a more palatable and natural alternative for gestational diabetes screening, potentially improving patient experience and compliance.
What could go wrong
This is an early-stage observational study with only 150 participants. Grape juice may not provide the same diagnostic accuracy as the standard glucola drink, and results may not apply to all pregnant individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion Criteria: Pregnant individuals scheduled for routine GCT at 24-28 weeks. Well-dated pregnancy (confirmed first-trimester ultrasound). Willingness to comply with study protocol. Exclusion Criteria: High-risk individuals requiring direct 100g OGTT (e.g., prior GDM, BMI \>40, PCOS). Intolerance to the alternative drink. Gastrointestinal conditions affecting glucose absorption such as active bowel disiease. Recent corticosteroid administration for fetal lung maturity after standard GCT.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy - prenatal testing are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pregnancy - prenatal testing

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bnai Zion Medical Center

    Haifa, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.